|
RARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.757700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.118100E-02 |
| Normal-vs-Stage2 |
5.932400E-02 |
| Normal-vs-Stage3 |
6.447700E-04 |
| Normal-vs-Stage4 |
8.276500E-03 |
| Stage1-vs-Stage2 |
4.599000E-01 |
| Stage1-vs-Stage3 |
4.995700E-02 |
| Stage1-vs-Stage4 |
2.267600E-01 |
| Stage2-vs-Stage3 |
5.365600E-01 |
| Stage2-vs-Stage4 |
7.457000E-01 |
| Stage3-vs-Stage4 |
7.906000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.475900E-03 |
| Normal-vs-AfricanAmerican |
7.581000E-01 |
| Normal-vs-Asian |
6.048300E-02 |
| Caucasian-vs-AfricanAmerican |
2.018400E-01 |
| Caucasian-vs-Asian |
9.965200E-01 |
| AfricanAmerican-vs-Asian |
2.997400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.537900E-03 |
| Normal-vs-Female |
8.019700E-03 |
| Male-vs-Female |
5.189400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.485010E-01 |
| Normal-vs-Age(41-60Yrs) |
2.766800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.370400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.698500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.698200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.069200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.586800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.148200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.665400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.756200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.712400E-01 |
| Classical-VS-Follicular |
6.746600E-01 |
| Classical-VS-Other |
5.397000E-01 |
| Classical-VS-Normal |
1.345740E-02 |
| Tall-VS-Follicular |
2.618600E-01 |
| Tall-VS-Other |
8.631400E-01 |
| Tall-VS-Normal |
9.275100E-03 |
| Follicular-VS-Other |
5.706400E-01 |
| Follicular-VS-Normal |
1.869570E-01 |
| Other-VS-Normal |
8.577900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.818100E-03 |
| Normal-vs-N1 |
6.501700E-03 |
| N0-vs-N1 |
4.290600E-01 |
|
|
